1 Min Read
Sept 19 (Reuters) - Glenmark Pharmaceuticals Ltd
* Says Glenmark Pharmaceuticals receives ANDA approval for desonide ointment, 0.05% Source text - bit.ly/2w3Zohv Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.